Europe PMC
open access
Localized nanomedicine for urologic cancers: anatomy-guided design and clinical translation
Bladder, prostate, and renal cancers differ in their anatomical locations, tissue structures, and routes of clinical intervention. Conventional systemic treatments are often limited by nonspecific biodistribution, insufficient tumor accumulation, and toxicity. Localized nanomedicine delivery offers
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cell- and biological-based drug delivery vectors for cancer treatment.#476924
- Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)#1111596
- Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer#1320353
- Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#242229
- Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#240444
Record · ID 1414827
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive